Resumen de acción VIVO
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Competidores de Meridian Bioscience, Inc.
Historial de precios y rendimiento
Historical stock prices | |
---|---|
Current Share Price | US$33.97 |
52 Week High | US$34.38 |
52 Week Low | US$21.09 |
Beta | 0.23 |
1 Month Change | 2.29% |
3 Month Change | 6.02% |
1 Year Change | 54.34% |
3 Year Change | 295.23% |
5 Year Change | 128.75% |
Change since IPO | 6,030.20% |
Noticias y actualizaciones recientes
Recent updates
Meridian Bioscience Non-GAAP EPS of $0.16 misses by $0.01, revenue of $67.8M beats by $1M
Aug 05Meridian Bioscience: High-Probability Merger Arbitrage
Jul 26Meridian Bioscience downgraded at William Blair on $1.53B acquisition
Jul 07Meridian Bioscience (NASDAQ:VIVO) Has A Pretty Healthy Balance Sheet
Jun 27Meridian Bioscience: Correctly Valued
Jun 26Many Would Be Envious Of Meridian Bioscience's (NASDAQ:VIVO) Excellent Returns On Capital
Jun 09Meridian Bioscience: Deceptively Priced
Mar 14Meridian Bioscience (NASDAQ:VIVO) Looks To Prolong Its Impressive Returns
Feb 03These 4 Measures Indicate That Meridian Bioscience (NASDAQ:VIVO) Is Using Debt Safely
Jul 19If The COVID-19 Delta Variant Spreads This Fall, Meridian Is Still A Buy
Jul 08Meridian Bioscience (NASDAQ:VIVO) Might Become A Compounding Machine
May 10Meridian Bioscience, Inc. 2021 Q2 - Results - Earnings Call Presentation
May 08Meridian Bioscience (NASDAQ:VIVO) Seems To Use Debt Rather Sparingly
Mar 31Have Insiders Been Buying Meridian Bioscience, Inc. (NASDAQ:VIVO) Shares?
Mar 11Investors Who Bought Meridian Bioscience (NASDAQ:VIVO) Shares A Year Ago Are Now Up 185%
Feb 24Need To Know: Analysts Are Much More Bullish On Meridian Bioscience, Inc. (NASDAQ:VIVO) Revenues
Feb 09Meridian expands production capacity for COVID-19 tests with NIH funding
Feb 03Should We Be Excited About The Trends Of Returns At Meridian Bioscience (NASDAQ:VIVO)?
Jan 27Does Meridian Bioscience (NASDAQ:VIVO) Deserve A Spot On Your Watchlist?
Jan 13Rentabilidad de los accionistas
VIVO | US Medical Equipment | Mercado US | |
---|---|---|---|
7D | 0.06% | 0.2% | 3.3% |
1Y | 54.3% | -1.9% | 25.0% |
Rentabilidad vs. Industria: VIVO superó al sector US Medical Equipment , que obtuvo un rendimiento del -3.7% el año pasado.
Rentabilidad vs. Mercado: VIVO superó al mercado US, que obtuvo un rendimiento del 19.3% el año pasado.
Volatilidad de los precios
VIVO volatility | |
---|---|
VIVO Average Weekly Movement | 2.3% |
Medical Equipment Industry Average Movement | 8.2% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: VIVO no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de VIVO (2%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
Fundada | Empleados | CEO | Página web |
---|---|---|---|
1976 | 704 | Jack Kenny | www.meridianbioscience.com |
Resumen de fundamentos de Meridian Bioscience, Inc.
Estadísticas fundamentales de VIVO | |
---|---|
Capitalización bursátil | US$1.49b |
Beneficios(TTM) | US$42.46m |
Ingresos (TTM) | US$333.02m |
35.2x
Ratio precio-beneficio (PE)4.5x
Ratio precio-ventas (PS)¿Está VIVO sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
Cuenta de resultados (TTM) de VIVO | |
---|---|
Ingresos | US$333.02m |
Coste de los ingresos | US$144.66m |
Beneficio bruto | US$188.36m |
Otros gastos | US$145.90m |
Beneficios | US$42.46m |
Últimos beneficios comunicados
Sep 30, 2022
Próxima fecha de beneficios
n/a
Beneficios por acción (BPA) | 0.96 |
Margen bruto | 56.56% |
Margen de beneficio neto | 12.75% |
Ratio deuda/patrimonio | 6.8% |
¿Cómo se ha desempeñado VIVO a largo plazo?
Ver rendimiento histórico y comparativa